Shai Yarkoni

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Prophylactic approaches to graft versus host disease (GvHD) have employed both phenotypic reduction of T cells and selective elimination of host-primed donor T cells in vitro and in vivo. An additional approach to GvHD prophylaxis by functional depletion of apoptosis-sensitive donor T cells without host-specific sensitization ex vivo showed remarkable(More)
  • 1